| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.013 | 0.9 |